Troglitazone not only reduced insulin resistance but also improved myotonia in a patient with myotonic dystrophy.
Kashiwagi
K
K
First Department of Internal Medicine, Neurological Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Nagafuchi
S
S
Sekiguchi
N
N
Yamagata
A
A
Iwata
I
I
Furuya
H
H
Kato
M
M
Niho
Y
Y
D000328:Adult; D002839:Chromans / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D009223:Myotonic Dystrophy / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D016896:Treatment Outcome; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone